| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |